Alcohol Withdrawal Syndrome (AWS): Diagnosis & Severity

The pattern I see most often is a patient who has had three or four previous withdrawals, managed them at home, and genuinely believes the fifth one will be the same. It usually is not. The brain has been sensitised by each prior withdrawal, and what was a five-day headache and anxiety the first time around can become a seizure by the fourth. By the time families contact us, they have already missed the window where outpatient management was safe.

What Is Alcohol Withdrawal Syndrome?

Alcohol withdrawal syndrome is what happens when a brain that has adapted to chronic alcohol exposure suddenly loses that input. To understand why, you need to know what alcohol does to the brain in the first place.

Alcohol enhances GABA-A receptor activity. GABA (gamma-aminobutyric acid) is the brain’s main inhibitory neurotransmitter, it slows things down. Alcohol also suppresses NMDA glutamate receptors, which drive excitation. Drink heavily for long enough, and the brain compensates: it downregulates GABA-A sensitivity and upregulates NMDA activity to restore balance. The brain recalibrates around a baseline that includes alcohol.

Remove the alcohol and the compensations stay in place. Suddenly you have reduced inhibition and increased excitation with no counterweight. The result is a hyperexcitable central nervous system, and that is AWS.

DSM-5 Criteria for Alcohol Withdrawal: What Clinicians Actually Assess

The DSM-5 requires four conditions to diagnose alcohol withdrawal syndrome. First, the person has been drinking heavily for a sustained period. DSM-5 deliberately does not specify an exact amount or duration, moderate to severe alcohol use disorder is the clinical backdrop. Second, alcohol use stops or is substantially reduced. Third, at least two of the following eight symptoms appear within hours to a few days of stopping: autonomic hyperactivity (sweating, tachycardia above 100 bpm), increased hand tremor, insomnia, nausea or vomiting, transient visual or auditory or tactile hallucinations, psychomotor agitation, anxiety, and generalised tonic-clonic seizures. Fourth, the symptoms cause clinically significant distress or functional impairment and are not explained by another medical condition or substance.

One point competitors often gloss over: DSM-5 includes a specifier for perceptual disturbances. This applies when hallucinations occur with intact reality testing, meaning the patient knows the experience is not real. That distinction matters clinically. A patient who hears voices and believes they are real is closer to full delirium; a patient who sees shadows and knows they are not there is not yet in delirium but is deteriorating. The ICD-10-CM codes reflect this: F10.239 for withdrawal without perceptual disturbances, F10.232 for withdrawal with perceptual disturbances.

Alcohol withdrawal, by definition, can only occur in the context of moderate or severe alcohol use disorder. You cannot code it alongside a mild AUD. This is not a minor bureaucratic detail, it reflects the biological reality that physiological dependence requires sustained, heavy exposure.

AWS Symptom Timeline: What Happens Hour by Hour

Timing is one of the most clinically useful features of AWS. If symptoms appear outside these windows, consider another diagnosis.

This table is a guide, not a guarantee. Patients with severe dependence or prior complicated withdrawals can seize earlier. Some reach delirium tremens past 72 hours. Use the timeline to calibrate suspicion, not to dismiss risk.

Severity Grading: The CIWA-Ar Scale

The Clinical Institute Withdrawal Assessment for Alcohol, revised (CIWA-Ar) is the standard tool for grading AWS severity. It scores ten items: nausea and vomiting, tremor, paroxysmal sweats, anxiety, agitation, tactile disturbances, auditory disturbances, visual disturbances, headache or fullness in the head, and orientation and clouding of sensorium. Each item is scored 0 to 7 except orientation, which is scored 0 to 4. Maximum score is 67.

Symptom-triggered dosing, giving benzodiazepines only when CIWA-Ar crosses a threshold, uses less medication and shortens treatment duration compared to fixed-dose regimens, according to multiple randomised trials. However, symptom-triggered dosing requires staff who can reliably perform the assessment every one to two hours. In settings where that is not possible, a fixed-dose taper is safer.

When You Cannot Use CIWA-Ar

CIWA-Ar requires the patient to cooperate with questioning. It does not work in patients with severe cognitive impairment, significant psychiatric comorbidity, or delirium. In those cases, clinicians fall back on objective vitals, heart rate above 100, blood pressure above 150/90, temperature above 38°C, and clinical judgement. Some centres use the MINDS (Minnesota Detoxification Scale) in these situations.

The Kindling Effect: Why Each Withdrawal Can Be Worse

The kindling effect is the most clinically important concept in AWS that most patients and families do not know about. Each episode of withdrawal sensitises the brain. NMDA receptor upregulation becomes more pronounced with each successive withdrawal. Seizure threshold lowers. The withdrawal that was manageable becomes dangerous, then life-threatening, with no increase in alcohol consumption needed to explain it.

Clinically, this means a patient with five prior withdrawals is not a candidate for home detox even if the previous four went smoothly. The risk profile has changed. We use prior withdrawal history as a primary risk stratifier, often more than current drinking volume.

Alcohol Withdrawal Seizures

Withdrawal seizures are generalised tonic-clonic events. They occur most commonly between 24 and 48 hours after the last drink. Most are single and self-limiting, lasting one to three minutes. But roughly 3% of patients who seize will progress to status epilepticus without treatment.

The first-line treatment for withdrawal seizures is a benzodiazepine, typically intravenous diazepam or lorazepam. Phenytoin does not prevent further withdrawal seizures and is not recommended for this indication. Phenobarbital is used in refractory cases or as an adjunct when benzodiazepine doses become dangerously high.

One thing families often ask: will an anticonvulsant from a previous prescription prevent a seizure? The answer is usually no. Withdrawal seizures are driven by the neurochemical environment of GABA-A downregulation and NMDA overactivity. Standard antiepileptic drugs do not address that mechanism the way benzodiazepines do.

Delirium Tremens: The Life-Threatening End of the Spectrum

Delirium tremens (DTs) develops in roughly 5% of people experiencing AWS. It is not just confusion. It is a syndrome of severe autonomic instability, fluctuating consciousness, profound agitation, and often psychotic features, all occurring simultaneously. Untreated DTs carry a mortality rate of up to 15%. With aggressive treatment in an ICU setting, that falls below 1%.

Onset is typically 48 to 72 hours after the last drink, though it can appear up to five days later. The clinical picture includes hyperthermia, profuse sweating, tachycardia above 120 bpm, hypertension, and disorientation so severe the patient cannot state the year or recognise family members.

Risk factors for DTs include a prior history of DTs, prior withdrawal seizures, longer duration of heavy drinking, older age, concurrent infection or illness, and a CIWA-Ar score above 20 on presentation. The presence of any two of these should prompt inpatient admission regardless of how the patient looks at the time of assessment.

Treatment is aggressive IV benzodiazepine dosing, often requiring doses far higher than clinicians unfamiliar with AWS expect. Lorazepam or diazepam IV are first-line. Thiamine 500mg IV three times daily is given alongside to prevent Wernicke’s encephalopathy, which can be triggered or worsened by the metabolic stress of DTs.

The Role of Benzodiazepines in AWS Treatment

Benzodiazepines are the first-line pharmacological treatment for AWS across all severity levels that require medication. They work by directly enhancing GABA-A receptor activity, substituting for alcohol’s inhibitory effect and allowing a controlled, gradual reduction in CNS excitation.

Diazepam (long-acting) and chlordiazepoxide are preferred in most settings because their long half-lives produce a smoother taper. Lorazepam (shorter-acting) is preferred in patients with liver disease because it does not require hepatic oxidation, it is conjugated directly to glucuronide. This matters enormously in a patient with alcoholic hepatitis or cirrhosis, where impaired liver function means long-acting benzodiazepines can accumulate to toxic levels.

Adjunctive medications used alongside benzodiazepines include carbamazepine (evidence-based for mild to moderate AWS, particularly in outpatient settings in Europe), gabapentin, and valproate. None of these replace benzodiazepines in severe AWS or DTs.

Wernicke’s Encephalopathy: The Complication That Hides Inside AWS

Wernicke’s encephalopathy is caused by thiamine (vitamin B1) deficiency, which is almost universal in people with severe alcohol dependence. Alcohol impairs thiamine absorption, and people who drink heavily often eat poorly. Thiamine is essential for glucose metabolism in the brain.

The classic triad is confusion, oculomotor dysfunction (eye movement abnormalities), and ataxia (loss of coordination). Most people know this triad. What most people do not know is that all three features occur together in fewer than 20% of cases. More often, you get one or two, and the diagnosis is missed.

If Wernicke’s is missed and glucose is administered without thiamine first, the thiamine demand spikes and the encephalopathy worsens acutely. This is why IV thiamine is given before or alongside any dextrose-containing fluids in any patient with suspected alcohol dependence. It is a simple, cheap intervention that prevents irreversible neurological damage.

Untreated Wernicke’s progresses to Korsakoff syndrome, a permanent amnestic disorder where the person cannot form new memories and often confabulates. That outcome is largely preventable with prompt thiamine replacement.

Alcohol Withdrawal Neuropathy and Long-Term Neurological Effects

Beyond the acute syndrome, long-term heavy drinking causes peripheral nerve damage that does not resolve with withdrawal alone. Alcoholic neuropathy produces burning pain, numbness, and weakness in the feet and lower legs. Patients often describe it as walking on broken glass. If you recognise this symptom pattern in yourself or someone you care for, alcoholic neuropathy warrants its own clinical assessment and treatment plan separate from withdrawal management.

Outpatient vs. Inpatient Withdrawal Management

Not every person withdrawing from alcohol needs a hospital bed. The decision depends on severity grading, social circumstances, and risk factors.

Outpatient withdrawal is not less serious medical management. It still requires a prescription protocol, typically chlordiazepoxide or diazepam tapering over five to seven days, daily or twice-daily clinical contact in the first 72 hours, and a clear escalation plan. The patient and anyone staying with them must know the warning signs that require emergency services: seizure, severe confusion, chest pain, temperature above 38.5°C.

Medications to Support Long-Term Recovery After Withdrawal

Getting through withdrawal is the beginning, not the outcome. Once the acute syndrome has resolved, relapse risk is high without pharmacological support. The most evidence-based options are naltrexone (opioid receptor antagonist that reduces the reward signal from drinking), acamprosate (modulates NMDA and GABA activity to reduce protracted withdrawal discomfort), and disulfiram (aversive deterrent that causes an unpleasant reaction if alcohol is consumed). For patients wanting to explore what is available, a full overview of medication to stop drinking alcohol covers these options in detail.

If someone you know has been through withdrawal more than once, that pattern itself is diagnostic. The DSM-5 defines alcohol use disorder on a spectrum from mild to severe, and repeated physiological withdrawal is one of the eleven criteria. The kindling effect means that each subsequent withdrawal carries more neurological risk. Repeated withdrawal cycles, each one more complicated than the last, are not a character flaw or a failure of willpower. They are the clinical signature of a brain that has been neurobiologically altered by sustained alcohol exposure.

At Phuket Island Rehab, we manage medically supervised alcohol withdrawal as the first phase of a structured treatment programme. The clinical team assesses CIWA-Ar scores through the acute phase, adjusts benzodiazepine dosing in real time, monitors for Wernicke’s, and builds a post-withdrawal plan that includes pharmacological relapse prevention. Patients who have complicated withdrawal histories or prior DTs are managed in close collaboration with our medical team. If you are in Thailand or considering treatment abroad, we can talk through what medically safe detox looks like for your specific history.

Alcohol withdrawal syndrome is a neurobiological process driven by the brain’s adaptation to chronic alcohol exposure. When heavy drinking stops, GABA-A inhibition drops and NMDA excitation spikes, producing a hyperexcitable state that ranges from tremor and anxiety in mild cases to seizures and delirium tremens at the severe end. The CIWA-Ar scale is the validated tool for grading severity and guiding treatment decisions. DSM-5 diagnosis requires at least two of eight specific symptoms, a history of significant alcohol use, and the exclusion of other medical causes. Benzodiazepines are the cornerstone of pharmacological treatment, with the choice of agent adjusted for liver function. Thiamine replacement is non-negotiable alongside any withdrawal management to prevent Wernicke’s encephalopathy.

The single most important practical takeaway is this: prior withdrawal history predicts current risk better than drinking volume alone. A patient who has had DTs once will likely have DTs again, and probably more severe. The kindling effect is real, it is progressive, and it is preventable with early, properly graded medical intervention. Home detox without clinical oversight is not a cautious option for someone with a complicated withdrawal history. It is a gamble. According to the WHO, alcohol accounts for 3 million deaths per year globally, and many of those deaths occur not from chronic liver disease but from acute, under-recognised medical events during unmanaged withdrawal. As Dr. Ponlawat Pitsuwan of Phuket Island Rehab puts it: “The patient who tells me their last four detoxes were fine is the one I worry about most. The brain keeps score, and the fifth withdrawal does not negotiate.”

What are the first signs of alcohol withdrawal syndrome?

The first signs of alcohol withdrawal typically appear within 6 to 12 hours of the last drink and include hand tremor, sweating, elevated heart rate, nausea, and anxiety. These early symptoms reflect autonomic hyperactivity as the brain’s GABA-A inhibitory system loses alcohol’s support. Most people mistake early withdrawal for a hangover, which is why the timing distinction matters: hangover symptoms peak around 8 to 12 hours and improve; withdrawal symptoms in dependent drinkers continue to worsen through the first 24 to 72 hours.

How dangerous is alcohol withdrawal without medical treatment?

Alcohol withdrawal without medical treatment can be life-threatening, particularly for people with a history of prior seizures or delirium tremens. Unmanaged withdrawal carries a risk of generalised tonic-clonic seizures in roughly 5 to 10% of cases and delirium tremens in roughly 5%, with DTs carrying a mortality rate of up to 15% untreated. Even for people with no prior complicated withdrawal, the risk is not predictable enough to manage safely at home without clinical input.

How long does alcohol withdrawal syndrome last?

Acute alcohol withdrawal syndrome typically resolves within five to seven days for most people. The most dangerous window, for seizures and delirium tremens, is between 24 and 72 hours after the last drink. Some patients experience protracted withdrawal, with anxiety, sleep disturbance, and mood instability lasting weeks to months, this is sometimes called post-acute withdrawal syndrome (PAWS) and reflects slower normalisation of glutamate and GABA receptor function.

What is the CIWA-Ar scale and how is it used?

The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, revised) is a validated 10-item assessment tool used to grade the severity of alcohol withdrawal and guide treatment decisions. Scores below 8 indicate mild withdrawal managed with monitoring and support; scores above 15 indicate severe withdrawal requiring benzodiazepines and inpatient care; scores above 20 signal high risk for delirium tremens. Clinicians repeat the assessment every one to two hours during the acute phase to track trajectory and adjust medication doses in real time.

Can alcohol withdrawal cause hallucinations?

Yes, alcohol withdrawal can cause hallucinations, most commonly visual, though auditory and tactile hallucinations also occur. These typically appear between 12 and 24 hours after the last drink. A key distinction: early withdrawal hallucinations often occur with intact reality testing, meaning the patient recognises that what they are seeing or hearing is not real. This is termed alcoholic hallucinosis and carries a specific DSM-5 specifier. When reality testing breaks down and disorientation sets in, the patient has progressed toward delirium tremens, which is a medical emergency.

What is the difference between alcohol withdrawal and delirium tremens?

Alcohol withdrawal is the broader syndrome that ranges from mild to severe; delirium tremens is the most severe presentation at the far end of that spectrum. DTs develop in roughly 5% of people with AWS, typically 48 to 72 hours after the last drink, and involve severe autonomic instability, high fever, profound disorientation, and agitated psychosis occurring simultaneously. Standard AWS can be managed in many settings; delirium tremens requires ICU-level care with high-dose IV benzodiazepines and intensive monitoring.

What medications are used to treat alcohol withdrawal syndrome?

Benzodiazepines are the first-line treatment for alcohol withdrawal syndrome because they directly substitute for alcohol’s effect on GABA-A receptors and reduce seizure risk. Diazepam and chlordiazepoxide are preferred in most patients due to their long half-lives; lorazepam is used when liver function is compromised. Thiamine is given alongside to prevent Wernicke’s encephalopathy. Adjunctive options including carbamazepine and gabapentin have evidence in mild to moderate withdrawal. Phenobarbital is reserved for refractory or benzodiazepine-resistant cases.